Albicans and C. Neoformans. Both cause life-threatening, invasive attacks in immunocompromised patients–for example, those contaminated with HIV or undergoing bone-marrow transplantation. Both fungi, which are distantly related in evolution, have different attributes governing their virulence in human beings. For C. Albicans, a transition between different morphological forms plays a major part, whereas for C. Neoformans, synthesis of a polysaccharide capsule is normally key.Before June 30 The rest of the balance of the purchase price will be produced on or, 2010. THE BUSINESS plans to financing the acquisition with existing money and operating cash flow, and will explore possibilities for financing from commercial banks, if required. This acquisition represents a strategic move in our evolution to a vertically integrated pharmaceutical firm and we expect it’ll lay the foundation for a significant contribution to our profitability in the arriving years, said Mr. Senshan Yang, Chairman and CEO of China Medicine. Particularly, the acquisition of LifeTech we can enhance our product line with high margin pharmaceuticals and improve our developing capabilities for existing propriety items.